BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients

被引:6
|
作者
Lopez-Munoz, Eunice [1 ]
Hernandez-Zarco, Adelina [1 ]
Garcia-Hernandez, Normand [1 ]
Alvarado-Cabrero, Isabel [2 ]
Zarco-Espinosa, Gelasio [3 ]
Salamanca-Gomez, Fabio
Arenas-Aranda, Diego [1 ]
机构
[1] Hosp Pediat Mexico City, Unidad Invest Med Genet Humana, Ctr Med Nacl Siglo XXI CMN S XXI, Inst Mexicano Seguro Social IMSS, Mexico City 06720, DF, Mexico
[2] Hosp Oncol, Serv Patol, CMN SXXI, IMSS, Mexico City 06720, DF, Mexico
[3] Hosp Oncol, Serv Tumores Mama, CMN S XXI, IMSS, Mexico City 06720, DF, Mexico
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2012年 / 14卷 / 08期
关键词
BIK/NBK; Estrogen receptor; Breast cancer; ENDOPLASMIC-RETICULUM BIK; BCL-2 PROTEIN FAMILY; CELL-DEATH; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; MITOCHONDRIAL APOPTOSIS; PROTEASOME INHIBITORS; AROMATASE INHIBITORS; BH3-ONLY PROTEIN; DRUG-RESISTANCE;
D O I
10.1007/s12094-012-0845-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study is to determine the association between the BIK/NBK gene expression and estrogen receptor alpha expression. We determined the association of BIK/NBK gene expression by real time quantitative reverse transcription polymerase chain reaction and estrogen receptor alpha expression by immunohistochemistry in samples of breast cancer tissue. We found a statistically significant correlation of BIK/NBK gene expression with the estrogen receptor alpha expression (rho = 0.751, p = 0.004). For verify differences of BIK/NBK gene expression among ER alpha+ and ER alpha- breast cancer tissues, Mann-Whitney U test was performed, obtaining significant differences. BIK/NBK gene expression may have important clinical implications and provide predictive, prognostic or therapeutic marker in breast cancer patients according to the estrogen receptor alpha expression.
引用
收藏
页码:586 / 591
页数:6
相关论文
共 50 条
  • [21] A novel cancer marker and potential therapeutic target
    Parri, M. P.
    Campagnoli, S. C.
    Grandi, A. G.
    Santi, A. S.
    De Camilli, E. D. C.
    Viale, G. V.
    Chiarugi, P. C.
    Terracciano, L. T.
    Pileri, P. P.
    Grifantini, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 178 - 178
  • [22] DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
    Song, L. J.
    Liu, Q.
    Meng, X. R.
    Li, S. H. L.
    Wang, L. X.
    Fan, Q. X.
    Xuan, X. Y.
    DIAGNOSTIC PATHOLOGY, 2016, 11 : 2
  • [23] Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer
    Yu Zhang
    Meng Zhang
    Fudong Yu
    Su Lu
    Huimin Sun
    Huamei Tang
    Zhihai Peng
    Journal of Experimental & Clinical Cancer Research, 34
  • [24] Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer
    Zhang, Yu
    Zhang, Meng
    Yu, Fudong
    Lu, Su
    Sun, Huimin
    Tang, Huamei
    Peng, Zhihai
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [25] DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
    L. J. Song
    Q. Liu
    X. R. Meng
    SH. L Li
    L. X. Wang
    Q. X. Fan
    X. Y. Xuan
    Diagnostic Pathology, 11
  • [26] BAK, BAX, and NBK/BIK Proapoptotic Gene Alterations in Iranian Patients with Ataxia Telangiectasia
    Isaian, Anna
    Bogdanova, Natalia V.
    Houshmand, Masoud
    Movahadi, Masoud
    Agamohammadi, Asghar
    Rezaei, Nima
    Atarod, Lida
    Sadeghi-Shabestari, Mahnaz
    Tonekaboni, Seyed Hasan
    Chavoshzadeh, Zahra
    Hassani, Seyed Mohammad Seyed
    Mirfakhrai, Reza
    Cheraghi, Taher
    Kalantari, Najmoddin
    Ataei, Mitra
    Dork-Bousset, Thilo
    Sanati, Mohammad Hossein
    JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 (01) : 132 - 137
  • [27] CEMIP as a potential biomarker and therapeutic target for breast cancer patients
    Xue, Jinqi
    Zhu, Xudong
    Qiao, Xinbo
    Wang, Yulun
    Bu, Jiawen
    Zhang, Xiaoying
    Ma, Qingtian
    Liang, Lu
    Sun, Lisha
    Liu, Caigang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (03): : 434 - 445
  • [28] Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker
    O'Conor, Christopher J.
    Chen, Tiffany
    Gonzalez, Ivan
    Cao, Dengfeng
    Peng, Yan
    BIOMARKERS IN MEDICINE, 2018, 12 (07) : 813 - 820
  • [29] LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases
    Botti, Gerardo
    Marra, Laura
    Malzone, Maria Gabriella
    Anniciello, Annamaria
    Botti, Chiara
    Franco, Renato
    Cantile, Monica
    CURRENT DRUG TARGETS, 2017, 18 (01) : 27 - 34
  • [30] MGMT as a potential prognostic marker in breast cancer
    Cirullo-Neto, J.
    Carvalho, K.
    Kagohara, L.
    Olivieri, E.
    Carraro, D.
    Cunha, I.
    Vassallo, J.
    Soares, F.
    Rocha, R.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 229 - 230